Citation 107393

XU,ZQ: BUCKHEIT,RW: STUP,TL: FLAVIN,MT: KHILEVICH,A: RIZZO,JD: LIN,L: ZEMBOWER,DE:. (1998). IN VITRO ANTI-HUMAN IMMUNODEFICIENCY VIRUS (HIV) ACTIVITY OF THE CHROMANONE DERIVATIVE, 12-OXOCALANOLIDE A, A NOVEL NNRTI.. 8(16)

Citation Details

Title	IN VITRO ANTI-HUMAN IMMUNODEFICIENCY VIRUS (HIV) ACTIVITY OF THE CHROMANONE DERIVATIVE, 12-OXOCALANOLIDE A, A NOVEL NNRTI.
Authors	XU,ZQ: BUCKHEIT,RW: STUP,TL: FLAVIN,MT: KHILEVICH,A: RIZZO,JD: LIN,L: ZEMBOWER,DE:
Year	1998
Volume	8
Issue	16

Summary

Year: 1998

Journal: Unknown

Organisms and Their Experiments (1)

Unknown organism

Experiment #	Pharmacology Type	Worktypes	Compound	Results
1	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CALANOLIDE A,12-OXO: (DL):	ACTIVE
2	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CALANOLIDE A,12-OXO: (DL):	ACTIVE
3	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CALANOLIDE A,12-OXO: (DL):	ACTIVE
4	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CALANOLIDE A,12-OXO: (DL):	ACTIVE
5	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CALANOLIDE A,12-OXO: (DL):	ACTIVE
6	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CALANOLIDE A,12-OXO: (DL):	WEAK ACTIVITY
7	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CALANOLIDE A,12-OXO: (DL):	ACTIVE
8	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CALANOLIDE A,12-OXO: (DL):	ACTIVE
9	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CALANOLIDE A,12-OXO: (DL):	ACTIVE
10	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CALANOLIDE A,12-OXO: (DL):	INACTIVE
11	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALANOLIDE A,12-OXO: (DL):	WEAK ACTIVITY
12	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CALANOLIDE A, 12-OXO: (+):	ACTIVE
13	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CALANOLIDE A, 12-OXO: (+):	ACTIVE
14	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CALANOLIDE A, 12-OXO: (+):	ACTIVE
15	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CALANOLIDE A, 12-OXO: (+):	ACTIVE
16	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CALANOLIDE A, 12-OXO: (+):	WEAK ACTIVITY
17	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CALANOLIDE A, 12-OXO: (+):	WEAK ACTIVITY
18	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CALANOLIDE A, 12-OXO: (+):	ACTIVE
19	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CALANOLIDE A, 12-OXO: (+):	ACTIVE
20	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CALANOLIDE A, 12-OXO: (+):	ACTIVE
21	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CALANOLIDE A, 12-OXO: (+):	INACTIVE
22	REVERSE TRANSCRIPTASE INHIBITION	PHARMACOLOGY OF COMPOUND - IN VITRO	CALANOLIDE A, 12-OXO: (+):	WEAK ACTIVITY
23	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CALANOLIDE A,12-OXO: (-):	ACTIVE
24	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CALANOLIDE A,12-OXO: (-):	ACTIVE
25	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CALANOLIDE A,12-OXO: (-):	ACTIVE
26	ANTIVIRAL ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTIBIOTIC MARKER CODE. (USE WITH 14XXX MPASPA)	CALANOLIDE A,12-OXO: (-):	WEAK ACTIVITY
27	CYTOTOXIC ACTIVITY	PHARMACOLOGY OF COMPOUND - IN VITROANTICANCER AND/OR CYTOTOXICITY MARKER CODE	CALANOLIDE A,12-OXO: (-):	WEAK ACTIVITY

Citation 107393

Citation Details

Summary

Organisms and Their Experiments (1)

Unknown organism

Show SPARQL Queries (1)

Query 1